We also examined expression levels of KYAT2 in liver tissue samples from patients who underwent liver resection surgery owing to hepatocellular carcinoma or hepatic cysts, and observed significantly increased protein levels of KYAT2 compared with those in pretreatment groups (Figure 2E,F). This evidence concerns the gene AADAT and hepatocellular carcinoma.